COVID-19 Vaccine Acceptance: We Need to Start Now
Open Access
- 4 January 2021
- journal article
- editorial
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 8 (2), ofaa658
- https://doi.org/10.1093/ofid/ofaa658
Abstract
In this perspective, we discuss the importance of developing a vaccine to help curb transmission of severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). The question remains: once a safe and effective vaccine is developed, will the public be willing to get it? We present information from one of the first tracking polls to assess public attitudes and perceptions towards a possible Coronavirus Disease 2019 (COVID-19) vaccine that suggests public hesitancy over a potential vaccine, concern regarding accelerating clinical trials, and unease over the vaccine approval process. Public health experts, government officials, advocates, and others in the scientific community should respect the signals of hesitancy and communicate sensitivity, applying lessons not only to how we message, but also in how we build this urgently needed vaccine if we are to have successful uptake once available.This publication has 4 references indexed in Scilit:
- The online anti-vaccine movement in the age of COVID-19Published by Elsevier BV ,2020
- Combating vaccine hesitancy and other 21st century social determinants in the global fight against measlesCurrent Opinion in Virology, 2020
- Vaccine Rejection and Hesitancy: A Review and Call to ActionOpen Forum Infectious Diseases, 2017
- Too Fast or Not Too Fast: The FDA's Approval of Merck's HPV Vaccine GardasilThe Journal of Law, Medicine & Ethics, 2012